Attached files

file filename
8-K - SUN HEALTHCARE GROUP INCform8k.htm
EXHIBIT 99.1
 


Sun Healthcare Group, Inc.
Reports 2010 Fourth-quarter Results and Normalized EPS of $0.43;
Achieves High-end of EBITDAR Guidance for the Year

Contact: Investor Inquiries (505) 468-2341
Media Inquiries (505) 468-4582

Irvine, Calif. (March 1, 2011)—Sun Healthcare Group, Inc. (NASDAQ GS: SUNH) today announced its operating results for the fourth quarter and year ended Dec. 31, 2010.

 
Normalized results for the fourth-quarter period ended Dec. 31, 2010:
 
·  
consolidated revenues rose 2.0 percent to $483.4 million, compared to the same period in 2009, driven by rate growth in nursing center business and volume growth in hospice and rehabilitation therapy business;
·  
consolidated adjusted EBITDAR increased 3.3 percent to $66.0 million and adjusted EBITDAR margin grew 10 basis points to 13.6 percent compared to the same period in 2009;
·  
diluted earnings per share from continuing operations was $0.43 on 25.8 million weighted- average diluted shares;
·  
normalized free cash flow was $5.5 million, bringing full year 2010 normalized free cash flow to $68.4 million; and
·  
results have been normalized to exclude $74.8 million of pre-tax restructuring costs, acquisition and disposal costs, and additions to reserves for prior-periods’ self-insurance and general liability matters.

 
Commenting on the Company’s fourth-quarter results, William A. Mathies, Sun’s chairman and chief executive officer, remarked, “I am pleased with our reported revenue and EBITDAR growth for the quarter and the year given the environmental challenges we faced in 2010 with the weak economy, soft census trends, reimbursement pressures and various regulatory changes affecting our sector. Our caregivers and leadership teams did an outstanding job embracing these challenges while maintaining their commitment to deliver quality care and achieving $250.6 million of normalized adjusted EBITDAR for fiscal 2010. In addition, we experienced positive admissions trends and rate growth in our nursing center business in alignment with our initiatives associated with caring for high-acuity short-stay patients.”
 
        Mathies added, “Our successful fourth-quarter completion of our previously announced restructuring was a milestone event for the Company in terms of creating stockholder value. With the restructuring now complete, I look forward to leading the Company in further value creation activities as we continue to grow our clinical capabilities and outcomes to assist our acute hospital partners in transitioning patients more quickly from acute care settings to our nursing centers. We remain committed to expanding our Rehab Recovery Suites® (RRS) footprint along with more aggressively investing in selected nursing centers to meet the needs of our markets and customer base. Our focus on growth will also include targeted acquisitions that expand our hospice business in synergistic markets and nursing center acquisitions that leverage our infrastructure.”
 
 

 
Segment Updates
 
On a year-over-year basis, revenue growth for the quarter in Sun’s inpatient services business totaled $8.2 million, or 1.9 percent. The inpatient services business reported normalized adjusted EBITDAR of $75.9 million for the quarter, with a normalized adjusted EBITDAR margin of 17.6 percent, up 40 basis points from the prior year. Our overall census and skilled mix for the quarter were down on a year-over-year basis by 150 basis points  and 120 basis points, respectively, although our ability to capture Medicare and managed care rate growth allowed us to improve our skilled revenue mix by 70 basis points.
 
Included in the inpatient segment, the SolAmor hospice business experienced same-store revenue growth of 2.1 percent with revenues increasing from $11.7 million in the fourth quarter of 2009 to $11.9 million in the fourth quarter of 2010, due to census expansion. SolAmor contributed $2.9 million of normalized adjusted EBITDAR for the quarter and a normalized adjusted EBITDAR margin of 24.7 percent. On Dec. 29, 2010, SolAmor completed the acquisition of Countryside Hospice Care, Inc., a Medicare-certified hospice company that provides services to approximately 200 hospice patients in Alabama and Georgia. With this acquisition, SolAmor expanded its hospice services to 10 states serving approximately 1,050 patients daily.
 
SunBridge continues to expand its RRS portfolio which targets short stay, high-acuity patients. At Dec. 31, 2010, RRS centers aggregated 1,992 beds, representing sequential quarter and year-over-year quarter bed increases of 20.9 percent and 30.3 percent, respectively. In 2011, the Company remains committed to this strategy and expects to develop an additional 600 beds, both in new locations and in existing RRS units.
 
SunDance, Sun’s rehabilitation therapy services business, experienced revenue growth of $6.5 million, or 14.0 percent, in the quarter on the strength of the 3.9 percent growth in revenue per contract coupled with growth in total contracts. For the quarter, SunDance reported adjusted EBITDAR of $2.6 million, down 4.9 percent from the prior year quarter due to the anticipated change in concurrent therapy reimbursement. For the fourth quarter, SunDance’s adjusted EBITDAR margin was down 100 basis points to 5.0 percent.
 
As expected, the implementation of the new Medicare payment system, the 1.7 percent market basket increase, the changes to concurrent therapy and the elimination of the look-back period were overall positive to the revenue growth and EBITDAR of the Company on a consolidated basis, notwithstanding the negative impact on SunDance’s EBITDAR margin. Experience to date affirms the Company’s positive view of the opportunity that these changes in the reimbursement system afford it, given its strategy of serving high-acuity patients, as well as the overall savings the changes should achieve for the Medicare program.
 
In line with the medical staffing industry as a whole, Sun’s medical staffing services business, CareerStaff, continued to be impacted negatively by the slow national economy. Accordingly, revenues from CareerStaff were down 3.5 percent to $22.7 million compared to revenues in the same quarter of 2009. Even with the challenging business environment, CareerStaff achieved adjusted EBITDAR of $1.5 million and an EBITDAR margin of 6.7 percent for the quarter.
 
Cash Flow and Capital Structure
 
       Sun ended 2010 with $81.2 million in cash and cash equivalents and $156.0 million of long-term debt. Sun’s normalized free cash flow for 2010 was $68.4 million after taking into account $53.5 million of cash used for capital expenditures in 2010 and after excluding the $15.1 million of cash used for debt redemption fees associated with the restructuring, the $26.9 million of cash used for professional fees associated with the restructuring and broker fees associated with the acquisition of Countryside.

 
 

 
Normalizing Items
 
Following approval by the stockholders of Sun’s former parent (“Old Sun”) in November, Old Sun successfully completed its previously announced restructuring involving the separation of its real estate assets and its operating assets into two separate, publicly traded companies. In connection with the restructuring transaction, the Company incurred pre-tax transaction costs totaling $29.1 million, consisting of legal, accounting and investment banker fees and related costs. The Company also incurred $29.2 million in pre-tax costs associated with the extinguishment of long-term debt in conjunction with the restructuring.

Normalization adjustments also include, on a pre-tax basis, the impact of $15.3 million of additions to reserves for prior periods’ self-insurance and general liabilities, $0.4 million of costs associated with the acquisition of Countryside, and $0.8 million of costs associated with the disposition of three nursing centers in the fourth quarter.
 
Affirmation of 2011 Guidance
 
The Company also announced that it is reaffirming its previously announced guidance for 2011.
 
Conference Call
 
As previously announced, investors and the general public are invited to listen to a conference call with Sun’s senior management on Wednesday, March 2, 2011, at 10 a.m. Pacific / 1 p.m. Eastern, to discuss the Company’s results for the fourth quarter and year end of 2010.

      To listen to the conference call, dial (888) 299-7236 and refer to Sun Healthcare Group. A recording of the call will be available from 4 p.m. Eastern on March 2, 2011, until 11:59 p.m. Eastern on April 1, 2011, by calling (888) 203-1112 and using access code 3702327.

About Sun Healthcare Group, Inc.

Sun Healthcare Group, Inc. (NASDAQ: SUNH) is a healthcare services company, serving principally the senior population, with consolidated annual revenues in excess of $1.9 billion and approximately 30,000 employees in 46 states. Sun's services are provided through its subsidiaries: as of Dec. 31, 2010, SunBridge Healthcare and its subsidiaries operate 164 skilled nursing centers,
16 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and eight mental health centers with an aggregate of 23,053 licensed beds in 25 states; SunDance Rehabilitation provides rehabilitation therapy services to affiliated and non-affiliated centers in 36 states; CareerStaff Unlimited provides medical staffing services in 39 states; and SolAmor Hospice provides hospice services in 10 states. For more information, go to www.sunh.com.

Forward-looking Statements
 
       Statements made in this release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "anticipate," "believe," "plan," "estimate," "expect," "hope," "intend," "may" and similar expressions. Forward-looking statements in this release include all statements regarding the expected results of operations, growth opportunities and plans and objectives of management for future operations, including expectations concerning the expansion of the Company’s RRS portfolio, acquisitions and the impact of changes in the Medicare payment system. Factors that could cause actual results to differ are identified in filings made by the Company with the Securities and Exchange Commission and include changes in Medicare and Medicaid reimbursements; the impact that healthcare reform legislation will have on the Company's business;
 
 

 
the ability to maintain the occupancy rates and payor mix at the Company's healthcare centers; potential liability for losses not covered by, or in excess of, insurance; the effects of government regulations and investigations; the ability of the Company to collect its accounts receivable on a timely basis; the significant amount of the Company's indebtedness; covenants in debt agreements that may restrict the Company's activities, including the Company's ability to make acquisitions and incur more indebtedness on favorable terms; the impact of the current economic downturn on the business; increasing labor costs and the shortage of qualified healthcare personnel; and the Company's ability to receive increases in reimbursement rates from government payors to cover increased costs. More information on factors that could affect the Company's business and financial results are included in Sun's filings made with the Securities and Exchange Commission, including its Annual Report on Forms 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun's web site, www.sunh.com. There may be additional risks of which the Company is presently unaware or that it currently deems immaterial.

The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company’s control. Sun cautions investors that any forward-looking statements made by Sun are not guarantees of future performance and are only made as of the date of this release. Sun disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

Adjusted EBITDA, adjusted EBITDAR and free cash flow, as used in this press release and in the accompanying tables, which are non-GAAP financial measures, are each reconciled to their respective GAAP recognized financial measures in the accompanying tables. In addition, the normalizing adjustments to adjusted EBITDAR, earnings per share and free cash flow as discussed in this press release and shown, together with normalizing adjustments to other financial measures, in the accompanying tables, are non-GAAP adjustments, and are reconciled to GAAP financial measures in the accompanying tables.

 
 

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
KEY INCOME STATEMENT FIGURES
 
CONSOLIDATED
 
(in thousands, except per share data)
 
             
   
For the
   
For the
 
   
Three Months Ended
   
Three Months Ended
 
   
December 31, 2010
   
December 31, 2009
 
             
             
Revenue
  $ 483,418     $ 473,827  
                 
Depreciation and amortization
    10,276       12,125  
                 
Interest expense, net
    8,698       11,905  
                 
Pre-tax income (loss)
    (48,956 )     16,631  
                 
Income tax (benefit) expense
    (17,026 )     6,821  
                 
(Loss) income from continuing operations
    (31,930 )     9,810  
                 
Loss from discontinued operations
    (446 )     (1,135 )
                 
Net (loss) income
  $ (32,376 )   $ 8,675  
                 
                 
Diluted earnings per share
  $ (1.26 )   $ 0.59  
                 
                 
                 
Adjusted EBITDAR
  $ 28,114     $ 59,465  
Margin - Adjusted EBITDAR
    5.8 %     12.5 %
                 
Adjusted EBITDAR normalized
  $ 65,977     $ 63,870  
Margin - Adjusted EBITDAR normalized
    13.6 %     13.5 %
                 
                 
                 
                 
Adjusted EBITDA
  $ 86     $ 41,093  
Margin - Adjusted EBITDA
    0.0 %     8.7 %
                 
Adjusted EBITDA normalized
  $ 37,949     $ 45,498  
Margin - Adjusted EBITDA normalized
    7.9 %     9.6 %
                 
                 
                 
                 
Pre-tax income continuing operations - normalized
  $ 18,975     $ 21,468  
                 
Income tax expense - normalized
  $ 7,779     $ 8,804  
                 
Income from continuing operations - normalized
  $ 11,196     $ 12,664  
                 
Diluted earnings per share from continuing operations - normalized
  $ 0.43     $ 0.86  
                 
Net income - normalized
  $ 10,750     $ 11,842  
                 
Diluted earnings per share - normalized
  $ 0.42     $ 0.80  
                 
                 
                 
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Income to Adjusted
 
     EBITDA and Adjusted EBITDAR".
               
See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison".
 

 
1 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
KEY INCOME STATEMENT FIGURES
 
CONSOLIDATED
 
(in thousands, except per share data)
 
             
   
For the
   
For the
 
   
Year Ended
   
Year Ended
 
   
December 31, 2010
   
December 31, 2009
 
             
             
Revenue
  $ 1,906,861     $ 1,880,776  
                 
Depreciation and amortization
    48,008       45,453  
                 
Interest expense, net
    43,064       49,327  
                 
Pre-tax income
    248       72,696  
                 
Income tax expense
    2,964       29,616  
                 
(Loss) income from continuing operations
    (2,716 )     43,080  
                 
Loss from discontinued operations
    (1,934 )     (4,409 )
                 
Net (loss) income
  $ (4,650 )   $ 38,671  
                 
                 
Diluted earnings per share
  $ (0.24 )   $ 2.63  
                 
                 
                 
Adjusted EBITDAR
  $ 205,722     $ 241,950  
Margin - Adjusted EBITDAR
    10.8 %     12.9 %
                 
Adjusted EBITDAR normalized
  $ 250,581     $ 250,655  
Margin - Adjusted EBITDAR normalized
    13.1 %     13.3 %
                 
                 
                 
                 
Adjusted EBITDA
  $ 121,388     $ 168,822  
Margin - Adjusted EBITDA
    6.4 %     9.0 %
                 
Adjusted EBITDA normalized
  $ 166,247     $ 177,527  
Margin - Adjusted EBITDA normalized
    8.7 %     9.4 %
                 
                 
                 
                 
Pre-tax income continuing operations - normalized
  $ 75,175     $ 82,705  
                 
Income tax expense - normalized
  $ 30,637     $ 33,720  
                 
Income from continuing operations - normalized
  $ 44,538     $ 48,985  
                 
Diluted earnings per share from continuing operations - normalized
  $ 2.31     $ 3.33  
                 
Net income - normalized
  $ 42,604     $ 45,237  
                 
Diluted earnings per share - normalized
  $ 2.21     $ 3.07  
                 
                 
                 
    See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Income to Adjusted
 
         EBITDA and Adjusted EBITDAR".
               
    See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison".
 
                 

 
2 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
CONSOLIDATED BALANCE SHEETS
 
(in thousands, except share data)
 
             
             
   
December 31, 2010
   
December 31, 2009
 
   
(audited)
   
(audited)
 
ASSETS
           
             
Current assets:
           
Cash and cash equivalents
  $ 81,163     $ 104,483  
Restricted cash
    15,329       24,034  
Accounts receivable, net
    218,040       220,319  
Prepaid expenses and other assets
    16,859       21,757  
Deferred tax assets
    69,800       68,415  
                 
 Total current assets
    401,191       439,008  
                 
Property and equipment, net
    139,860       622,682  
Intangible assets, net
    41,967       38,628  
Goodwill
    348,047       338,296  
Restricted cash, non-current
    350       3,317  
Deferred tax assets
    126,540       108,999  
Other assets
    23,803       20,264  
 
               
Total assets
  $ 1,081,758     $ 1,571,194  
                 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
Current liabilities:
               
Accounts payable
  $ 49,993     $ 57,109  
Accrued compensation and benefits
    61,518       58,953  
Accrued self-insurance obligations, current portion
    52,093       45,661  
Other accrued liabilities
    53,945       55,265  
Current portion of long-term debt and capital lease obligations
    11,050       46,416  
                 
Total current liabilities
    228,599       263,404  
                 
Accrued self-insurance obligations, net of current portion
    133,405       121,948  
Long-term debt and capital lease obligations, net of current portion
    144,930       654,132  
Unfavorable lease obligations, net
    9,815       12,663  
Other long-term liabilities
    52,566       69,983  
                 
Total liabilities
    569,315       1,122,130  
                 
                 
Stockholders' equity:
               
Preferred stock of $.01 par value, authorized 3,333,333 shares,
       zero shares were issued and outstanding as of December 31, 2010
       and authorized 10,000,000 shares, zero shares were issued and
       outstanding as of December 31, 2009
    -       -  
                 
Common stock of $.01 par value, authorized 41,666,667 shares,
       24,973,693 shares issued and outstanding as of December 31, 2010
       and authorized 125,000,000 shares, 43,764,240 shares issued and
       outstanding as of December 31, 2009
    250       438  
Additional paid-in capital
    720,854       655,666  
Accumulated deficit
    (208,661 )     (204,011 )
Accumulated other comprehensive loss, net
    -       (3,029 )
      512,443       449,064  
Total liabilities and stockholders' equity
  $ 1,081,758     $ 1,571,194  
                 

 
3 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
CONSOLIDATED INCOME STATEMENTS
 
(in thousands, except per share data)
 
             
   
For the
   
For the
 
   
Three Months Ended
   
Three Months Ended
 
   
December 31, 2010
   
December 31, 2009
 
   
(unaudited)
   
(unaudited)
 
             
Total net revenues
  $ 483,418     $ 473,827  
Costs and expenses:
               
Operating salaries and benefits
    273,556       266,522  
Self-insurance for workers' compensation and
      general and professional liability insurance
    27,104       18,122  
Operating administrative costs
    13,011       12,693  
Other operating costs
    98,660       97,422  
Center rent expense
    28,028       18,372  
General and administrative expenses
    16,273       14,011  
Depreciation and amortization
    10,276       12,125  
Provision for losses on accounts receivable
    4,583       5,592  
Interest, net of interest income of $92 and $74, respectively
    8,698       11,905  
Loss on extinguishment of debt, net
    29,221       -  
Transaction costs
    22,117       -  
Loss on sale of assets, net
    847       -  
Restructuring costs
    -       432  
Total costs and expenses
    532,374       457,196  
                 
(Loss) income before income taxes and discontinued operations
    (48,956 )     16,631  
Income tax (benefit) expense
    (17,026 )     6,821  
(Loss) income from continuing operations
    (31,930 )     9,810  
                 
Discontinued operations:
               
Loss from discontinued operations, net of related taxes
    (446 )     (1,136 )
Gain on disposal of discontinued operations, net of related taxes
    -       1  
Loss from discontinued operations, net
    (446 )     (1,135 )
                 
Net (loss) income
  $ (32,376 )   $ 8,675  
                 
                 
Basic income per common and common equivalent share:
               
(Loss) income from continuing operations
  $ (1.24 )   $ 0.67  
Loss from discontinued operations, net
    (0.02 )     (0.08 )
Net (loss) income
  $ (1.26 )   $ 0.59  
                 
Diluted income per common and common equivalent share:
               
(Loss) income from continuing operations
  $ (1.24 )   $ 0.67  
Loss from discontinued operations, net
    (0.02 )     (0.08 )
Net (loss) income
  $ (1.26 )   $ 0.59  
                 
Weighted average number of common and
     common equivalent shares outstanding:
         
Basic
    25,791       14,648  
Diluted
    25,791       14,746  


 
4 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
CONSOLIDATED INCOME STATEMENTS
 
(in thousands, except per share data)
 
             
   
For the
   
For the
 
   
Year Ended
   
Year Ended
 
   
December 31, 2010
   
December 31, 2009
 
   
(audited)
   
(audited)
 
             
Total net revenues
  $ 1,906,861     $ 1,880,776  
Costs and expenses:
               
Operating salaries and benefits
    1,077,859       1,056,265  
Self-insurance for workers' compensation and
      general and professional liability insurance
    70,806       63,740  
Operating administrative costs
    51,943       50,924  
Other operating costs
    390,008       384,655  
Center rent expense
    84,334       73,128  
General and administrative expenses
    60,842       62,068  
Depreciation and amortization
    48,008       45,453  
Provision for losses on accounts receivable
    20,568       21,174  
Interest, net of interest income of $315 and $383, respectively
    43,064       49,327  
Loss on extinguishment of debt, net
    29,221       -  
Transaction costs
    29,113       -  
Loss on sale of assets, net
    847       42  
Restructuring costs
    -       1,304  
Total costs and expenses
    1,906,613       1,808,080  
                 
Income before income taxes and discontinued operations
    248       72,696  
Income tax expense
    2,964       29,616  
(Loss) income from continuing operations
    (2,716 )     43,080  
                 
Discontinued operations:
               
Loss from discontinued operations, net of related taxes
    (1,934 )     (4,076 )
Loss on disposal of discontinued operations, net of related taxes
    -       (333 )
Loss from discontinued operations, net
    (1,934 )     (4,409 )
                 
Net (loss) income
  $ (4,650 )   $ 38,671  
                 
                 
Basic income per common and common equivalent share:
               
(Loss) income from continuing operations
  $ (0.14 )   $ 2.95  
Loss from discontinued operations, net
    (0.10 )     (0.30 )
Net (loss) income
  $ (0.24 )   $ 2.65  
                 
Diluted income per common and common equivalent share:
               
(Loss) income from continuing operations
  $ (0.14 )   $ 2.93  
Loss from discontinued operations, net
    (0.10 )     (0.30 )
Net (Loss) income
  $ (0.24 )   $ 2.63  
                 
Weighted average number of common and
     common equivalent shares outstanding:
         
Basic
    19,280       14,614  
Diluted
    19,280       14,714  
                 


 
5 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(in thousands)
 
             
   
For the
   
For the
 
   
Three Months Ended
   
Three Months Ended
 
   
December 31, 2010
   
December 31, 2009
 
   
(unaudited)
   
(unaudited)
 
             
Cash flows from operating activities:
           
Net income
  $ (32,376 )   $ 8,675  
Adjustments to reconcile net income to net cash provided by
               
operating activities, including discontinued operations:
               
Loss on extinguishment of debt
    14,126       -  
Depreciation and amortization
    10,279       12,128  
Amortization of favorable and unfavorable lease intangibles
    (493 )     (474 )
Provision for losses on accounts receivable
    4,747       5,597  
Loss on sale of assets, including discontinued operations, net
    847       (2 )
Stock-based compensation expense
    1,552       1,425  
Deferred taxes
    (16,566 )     8,984  
Changes in operating assets and liabilities, net of acquisitions:
               
Accounts receivable
    (6,445 )     (12,959 )
Restricted cash
    331       1,817  
Prepaid expenses and other assets
    (2,341 )     2,795  
Accounts payable
    1,786       3,433  
Accrued compensation and benefits
    574       (7,916 )
Accrued self-insurance obligations
    12,849       6,504  
Income taxes payable
    (1,605 )     -  
Other accrued liabilities
    (8,643 )     (11,721 )
Other long-term liabilities
    (872 )     (1,401 )
Net cash (used for) provided by operating activities
    (22,250 )     16,885  
                 
Cash flows from investing activities:
               
Capital expenditures
    (12,040 )     (12,854 )
Acquisitions, net of cash acquired
    (13,894 )     (14,936 )
Net cash used for investing activities
    (25,934 )     (27,790 )
                 
Cash flows from financing activities:
               
Borrowings of long-term debt
    415,000       (2,043 )
Principal repayments of long-term debt and capital lease obligations
    (322,041 )     -  
Distribution to non-controlling interest
    (36 )     -  
Distribution to Sabra Heatlh Care REIT, Inc.
    (66,862 )     -  
Dividends to stockholders
    (9,996 )     -  
Proceeds from issuance of common stock
    (608 )     26  
Deferred financing costs
    (24,460 )     -  
Net cash used for financing activities
    (9,003 )     (2,017 )
                 
Net (decrease) increase in cash and cash equivalents
    (57,187 )     (12,922 )
Cash and cash equivalents at beginning of period
    138,350       117,405  
Cash and cash equivalents at end of period
  $ 81,163     $ 104,483  
                 
Reconciliation of net cash provided by operating activities to free cash flow:
         
                 
Net cash (used for) provided by operating activities
  $ (22,250 )   $ 16,885  
Capital expenditures
    (12,040 )     (12,854 )
Cash used for professional fees on restructuring
    24,232       -  
Cash used for early redemption fees
    15,095       -  
Cash used for broker fees on acquisitions
    446       -  
Normalized free cash flow
  $ 5,483     $ 4,031  
                 
 
 

Normalized free cash flow is defined as net cash flow provided by operating activities less cash used for capital expenditures.  Normalized free cash flow is used by management to evaluate discretionary cash flow potentially available for debt service and other financing activities.

 
6 of 16

 

 
 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(in thousands)
 
             
   
For the
   
For the
 
   
Twelve Months Ended
   
Twelve Months Ended
 
   
December 31, 2010
   
December 31, 2009
 
   
(audited)
   
(audited)
 
             
Cash flows from operating activities:
           
Net income
  $ (4,650 )   $ 38,671  
Adjustments to reconcile net income to net cash provided by
               
operating activities, including discontinued operations:
               
Loss on extinguishment of debt
    14,126       -  
Depreciation and amortization
    48,023       45,465  
Amortization of favorable and unfavorable lease intangibles
    (1,945 )     (1,824 )
Provision for losses on accounts receivable
    21,175       21,196  
Loss on sale of assets, including discontinued operations, net
    847       605  
Stock-based compensation expense
    6,300       5,810  
Deferred taxes
    (1,590 )     27,003  
Changes in operating assets and liabilities, net of acquisitions:
               
Accounts receivable
    (18,945 )     (33,547 )
Restricted cash
    3,176       10,628  
Prepaid expenses and other assets
    5,671       2,940  
Accounts payable
    (1,842 )     (8,390 )
Accrued compensation and benefits
    2,519       (2,989 )
Accrued self-insurance obligations
    17,890       7,759  
Other accrued liabilities
    (9,919 )     (3,196 )
Other long-term liabilities
    (928 )     (1,223 )
Net cash provided by operating activities
    79,908       108,908  
                 
Cash flows from investing activities:
               
Capital expenditures
    (53,528 )     (54,312 )
Purchase of leased real estate
    -       (3,275 )
Proceeds from sale of assets held for sale
    -       2,174  
Acquisitions, net of cash acquired
    (13,894 )     (14,936 )
Net cash used for investing activities
    (67,422 )     (70,349 )
                 
Cash flows from financing activities:
               
Borrowings of long-term debt
    435,500       20,822  
Principal repayments of long-term debt and capital lease obligations
    (590,939 )     (46,292 )
Payment to non-controlling interest
    (2,025 )     (311 )
Distribution to non-controlling interest
    (105 )     (549 )
Distribution to Sabra Heatlh Care REIT, Inc.
    (66,862 )     -  
Dividends to stockholders
    (9,996 )     -  
Proceeds from issuance of common stock
    225,393       101  
Deferred financing costs
    (26,772 )     -  
Net cash used for financing activities
    (35,806 )     (26,229 )
                 
Net increase in cash and cash equivalents
    (23,320 )     12,330  
Cash and cash equivalents at beginning of period
    104,483       92,153  
Cash and cash equivalents at end of period
  $ 81,163     $ 104,483  
                 
Reconciliation of net cash provided by operating activities to free cash flow:
         
                 
Net cash provided by operating activities
  $ 79,908     $ 108,908  
Capital expenditures
    (53,528 )     (54,312 )
Cash used for professional fees on restructuring
    26,436       -  
Cash used for early redemption fees
    15,095       -  
Cash used for broker fees on acquisitions
    446       -  
Normalized free cash flow
  $ 68,357     $ 54,596  
                 
                 

Normalized free cash flow is defined as net cash flow provided by operating activities less cash used for capital expenditures.  Normalized free cash flow is used by management to evaluate discretionary cash flow potentially available for debt service and other financing activities.
 
7 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
RECONCILIATION OF NET INCOME TO EBITDA and EBITDAR
 
(in thousands)
 
             
   
For the
   
For the
 
   
Three Months Ended
   
Three Months Ended
 
   
December 31, 2010
   
December 31, 2009
 
   
(unaudited)
   
(unaudited)
 
             
 Total net revenues
  $ 483,418     $ 473,827  
                 
 Net (loss) income
  $ (32,376 )   $ 8,675  
                 
                 
 (Loss) income from continuing operations
    (31,930 )     9,810  
                 
 Income tax (benefit) expense
    (17,026 )     6,821  
                 
 Interest, net
    8,698       11,905  
                 
 Depreciation and amortization
    10,276       12,125  
                 
 EBITDA
  $ (29,982 )   $ 40,661  
                 
 Loss on extinguishment of debt, net
    29,221       -  
                 
 Loss on sale of assets, net
    847       -  
                 
 Restructuring costs
    -       432  
                 
 Adjusted EBITDA
  $ 86     $ 41,093  
                 
                 
 Center rent expense
    28,028       18,372  
                 
 Adjusted EBITDAR
  $ 28,114     $ 59,465  
                 
 
EBITDA is defined as earnings before loss on discontinued operations, income taxes, interest, net, depreciation and amortization.  Adjusted EBITDA is defined as EBITDA before loss on extinguishment of debt, restructuring costs and loss on sale of assets, net.  Adjusted EBITDAR is defined as Adjusted EBITDA before center rent expense. Adjusted EBITDA and Adjusted EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole.  Adjusted EBITDA and Adjusted EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability.  Adjusted EBITDA and Adjusted EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from Adjusted EBITDA and Adjusted EBITDAR are significant components in understanding and assessing finance performance, Adjusted EBITDA and Adjusted EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by or used in operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity.  Because Adjusted EBITDA and Adjusted EBTIDAR are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations, Adjusted EBITDA and Adjusted EBITDAR as presented may not be comparable to other similarly titled measures of other companies.
 
8 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
             
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA and ADJUSTED EBITDAR
 
(in thousands)
 
             
   
For the
   
For the
 
   
Year Ended
   
Year Ended
 
   
December 31, 2010
   
December 31, 2009
 
   
(audited)
   
(audited)
 
             
 Total net revenues
  $ 1,906,861     $ 1,880,776  
                 
 Net (loss) income
  $ (4,650 )   $ 38,671  
                 
                 
 (Loss) income from continuing operations
    (2,716 )     43,080  
                 
 Income tax expense
    2,964       29,616  
                 
 Interest, net
    43,064       49,327  
                 
 Depreciation and amortization
    48,008       45,453  
                 
 EBITDA
  $ 91,320     $ 167,476  
                 
 Loss on extinguishment of debt, net
    29,221       -  
                 
 Loss on sale of assets, net
    847       42  
                 
 Restructuring costs
    -       1,304  
                 
 Adjusted EBITDA
  $ 121,388     $ 168,822  
                 
                 
 Center rent expense
    84,334       73,128  
                 
 Adjusted EBITDAR
  $ 205,722     $ 241,950  
                 

 
EBITDA is defined as earnings before loss on discontinued operations, income taxes, interest, net, depreciation and amortization.  Adjusted EBITDA is defined as EBITDA before, loss on extinguishment of debt, restructuring costs and loss on sale of assets, net.  Adjusted EBITDAR is defined as Adjusted EBITDA before center rent expense.  Adjusted EBITDA and Adjusted EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole.  Adjusted EBITDA and Adjusted EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability.  Adjusted EBITDA and Adjusted EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from Adjusted EBITDA and Adjusted EBITDAR are significant components in understanding and assessing finance performance, Adjusted EBITDA and Adjusted EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by or used in operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity.  Because Adjusted EBITDA and Adjusted EBTIDAR are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations, Adjusted EBITDA and Adjusted EBITDAR as presented may not be comparable to other similarly titled measures of other companies.


 
9 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
                                     
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA and ADJUSTED EBITDAR
 
($ in thousands)
 
                                     
For the Three Months Ended December 31, 2010
 
 (unaudited)
 
                                     
   
Inpatient
Services
   
Rehabilitation
Therapy
Services
   
Medical
Staffing
Services
   
Other &
Corp Seg
   
Elimination
of Affiliated
Revenue
   
Consolidated
 
                                     
Nonaffiliated revenue
  $ 431,464     $ 29,889     $ 22,053     $ 12     $ -     $ 483,418  
                                                 
Affiliated revenue
    -       22,892       672       -       (23,564 )     -  
                                                 
Total revenue
  $ 431,464     $ 52,781     $ 22,725     $ 12     $ (23,564 )   $ 483,418  
                                                 
Income (loss) from continuing operations
  $ 36,547     $ 2,315     $ 1,116     $ (71,908 )   $ -     $ (31,930 )
                                                 
Income tax expense
    -       -       -       (17,026 )     -       (17,026 )
                                                 
Interest, net
    1,406       -       -       7,292       -       8,698  
                                                 
Depreciation and amortization
    9,013       194       189       880       -       10,276  
                                                 
EBITDA
  $ 46,966     $ 2,509     $ 1,305     $ (80,762 )   $ -     $ (29,982 )
                                                 
Loss on extinguishment of debt, net
    -       -       -       29,221       -       29,221  
                                                 
Loss on sale of assets, net
    847       -       -       -       -       847  
                                                 
Adjusted EBITDA
  $ 47,813     $ 2,509     $ 1,305     $ (51,541 )   $ -     $ 86  
                                                 
Center rent expense
    27,667       133       228       -       -       28,028  
                                                 
Adjusted EBITDAR
  $ 75,480     $ 2,642     $ 1,533     $ (51,541 )   $ -     $ 28,114  
                                                 
                                                 
Normalized Adjusted EBITDA
  $ 48,259     $ 2,509     $ 1,305     $ (14,124 )   $ -     $ 37,949  
Normalized Adjusted EBITDAR
  $ 75,926     $ 2,642     $ 1,533     $ (14,124 )   $ -     $ 65,977  
                                                 
                                                 
Adjusted EBITDA margin
    11.1 %     4.8 %     5.7 %                     0.0 %
                                                 
Adjusted EBITDAR margin
    17.5 %     5.0 %     6.7 %                     5.8 %
                                                 
 Normalized Adjusted EBITDA margin
    11.2 %     4.8 %     5.7 %                     7.9 %
                                                 
 Normalized Adjusted EBITDAR margin
    17.6 %     5.0 %     6.7 %                     13.6 %
                                                 
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Income to Adjusted EBITDA and
 
     Adjusted EBITDAR".
                                               
See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison".
                 
                                                 

 
10 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
                                     
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA and ADJUSTED EBITDAR
 
($ in thousands)
 
                                     
For the Year Ended December 31, 2010
 
(audited)
 
                                     
   
Inpatient
Services
   
Rehabilitation
Therapy
Services
   
Medical
Staffing
Services
   
Other &
Corp Seg
   
Elimination
of Affiliated
Revenue
   
Consolidated
 
                                     
Nonaffiliated revenue
  $ 1,697,444     $ 119,612     $ 89,765     $ 40     $ -     $ 1,906,861  
                                                 
Affiliated revenue
    -       86,476       2,036       -       (88,512 )     -  
                                                 
Total revenue
  $ 1,697,444     $ 206,088     $ 91,801     $ 40     $ (88,512 )   $ 1,906,861  
                                                 
Income (loss) from continuing operations
  $ 149,900     $ 14,073     $ 5,595     $ (172,284 )   $ -     $ (2,716 )
                                                 
Income tax expense
    -       -       -       2,964       -       2,964  
                                                 
Interest, net
    9,493       -       (1 )     33,572       -       43,064  
                                                 
Depreciation and amortization
    43,333       678       732       3,265       -       48,008  
                                                 
EBITDA
  $ 202,726     $ 14,751     $ 6,326     $ (132,483 )   $ -     $ 91,320  
                                                 
Loss on extinguishment of debt, net
    -       -       -       29,221       -       29,221  
                                                 
Loss on sale of assets, net
    847       -       -       -       -       847  
                                                 
Adjusted EBITDA
  $ 203,573     $ 14,751     $ 6,326     $ (103,262 )   $ -     $ 121,388  
                                                 
Center rent expense
    82,994       496       844       -       -       84,334  
                                                 
Adjusted EBITDAR
  $ 286,567     $ 15,247     $ 7,170     $ (103,262 )   $ -     $ 205,722  
                                                 
                                                 
Normalized Adjusted EBITDA
  $ 204,019     $ 14,751     $ 6,326     $ (58,849 )   $ -     $ 166,247  
Normalized Adjusted EBITDAR
  $ 287,013     $ 15,247     $ 7,170     $ (58,849 )   $ -     $ 250,581  
                                                 
                                                 
Adjusted EBITDA margin
    12.0 %     7.2 %     6.9 %                     6.4 %
                                                 
Adjusted EBITDAR margin
    16.9 %     7.4 %     7.8 %                     10.8 %
                                                 
 Normalized Adjusted EBITDA margin
    12.0 %     7.2 %     6.9 %                     8.7 %
                                                 
 Normalized Adjusted EBITDAR margin
    16.9 %     7.4 %     7.8 %                     13.1 %
                                                 
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Income to Adjusted EBITDA and
 
     Adjusted EBITDAR".
                                               
See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison".
                 
                                                 

 
11 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
                                     
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA and ADJUSTED EBITDAR
 
($ in thousands)
 
                                     
For the Three Months Ended December 31, 2009
 
(unaudited)
 
                                     
   
Inpatient
Services
   
Rehabilitation
Therapy
Services
   
Medical
Staffing
Services
   
Other &
Corp Seg
   
Elimination
of Affiliated
Revenue
   
Consolidated
 
                                     
Nonaffiliated revenue
  $ 423,228     $ 27,303     $ 23,289     $ 7     $ -     $ 473,827  
                                                 
Affiliated revenue
    -       18,998       262       -       (19,260 )     -  
                                                 
Total revenue
  $ 423,228     $ 46,301     $ 23,551     $ 7     $ (19,260 )   $ 473,827  
                                                 
Income (loss) from continuing operations
  $ 36,144     $ 2,506     $ 2,209     $ (31,049 )   $ -     $ 9,810  
                                                 
Income tax expense
    -       -       -       6,821       -       6,821  
                                                 
Interest, net
    2,881       -       (1 )     9,025       -       11,905  
                                                 
Depreciation and amortization
    11,004       141       179       801       -       12,125  
                                                 
EBITDA
  $ 50,029     $ 2,647     $ 2,387     $ (14,402 )   $ -     $ 40,661  
                                                 
Restructuring costs
    143       -       -       289       -       432  
                                                 
Adjusted EBITDA
  $ 50,172     $ 2,647     $ 2,387     $ (14,113 )   $ -     $ 41,093  
                                                 
                                                 
Center rent expense
    18,021       131       220       -       -       18,372  
                                                 
Adjusted EBITDAR
  $ 68,193     $ 2,778     $ 2,607     $ (14,113 )   $ -     $ 59,465  
                                              -  
                                                 
Normalized Adjusted EBITDA
  $ 54,577     $ 2,647     $ 2,387     $ (14,113 )   $ -     $ 45,498  
Normalized Adjusted EBITDAR
  $ 72,598     $ 2,778     $ 2,607     $ (14,113 )   $ -     $ 63,870  
                                                 
                                                 
Adjusted EBITDA margin
    11.9 %     5.7 %     10.1 %                     8.7 %
                                                 
Adjusted EBITDAR margin
    16.1 %     6.0 %     11.1 %                     12.5 %
                                                 
 Normalized Adjusted EBITDA margin
    12.9 %     5.7 %     10.1 %                     9.6 %
                                                 
 Normalized Adjusted EBITDAR margin
    17.2 %     6.0 %     11.1 %                     13.5 %
                                                 
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Income to Adjusted EBITDA and
 
     Adjusted EBITDAR".
                                               
See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison".
                 
                                                 

 
12 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
                                     
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA and ADJUSTED EBITDAR
 
($ in thousands)
 
                                     
For the Year Ended December 31, 2009
 
(audited)
 
                                     
   
Inpatient
Services
   
Rehabilitation
Therapy
Services
   
Medical
Staffing
Services
   
Other &
Corp Seg
   
Elimination
of Affiliated
Revenue
   
Consolidated
 
                                     
Nonaffiliated revenue
  $ 1,674,752     $ 105,366     $ 100,624     $ 34     $ -     $ 1,880,776  
                                                 
Affiliated revenue
    -       74,166       1,930       -       (76,096 )     -  
                                                 
Total revenue
  $ 1,674,752     $ 179,532     $ 102,554     $ 34     $ (76,096 )   $ 1,880,776  
                                                 
Income (loss) from continuing operations
  $ 156,537     $ 11,078     $ 8,610     $ (133,145 )   $ -     $ 43,080  
                                                 
Income tax expense
    -       -       -       29,616       -       29,616  
                                                 
Interest, net
    12,226       (2 )     (2 )     37,105       -       49,327  
                                                 
Depreciation and amortization
    41,325       540       780       2,808       -       45,453  
                                                 
EBITDA
  $ 210,088     $ 11,616     $ 9,388     $ (63,616 )   $ -     $ 167,476  
                                                 
Loss on sale of assets, net
    8       34       -       -       -       42  
                                                 
Restructuring costs
    143       -       -       1,161       -       1,304  
                                                 
Adjusted EBITDA
  $ 210,239     $ 11,650     $ 9,388     $ (62,455 )   $ -     $ 168,822  
                                                 
                                                 
Center rent expense
    71,728       480       920       -       -       73,128  
                                                 
Adjusted EBITDAR
  $ 281,967     $ 12,130     $ 10,308     $ (62,455 )   $ -     $ 241,950  
                                                 
                                                 
Normalized Adjusted EBITDA
  $ 218,944     $ 11,650     $ 9,388     $ (62,455 )   $ -     $ 177,527  
Normalized Adjusted EBITDAR
  $ 290,672     $ 12,130     $ 10,308     $ (62,455 )   $ -     $ 250,655  
                                                 
                                                 
Adjusted EBITDA margin
    12.6 %     6.5 %     9.2 %                     9.0 %
                                                 
Adjusted EBITDAR margin
    16.8 %     6.8 %     10.1 %                     12.9 %
                                                 
 Normalized Adjusted EBITDA margin
    13.1 %     6.5 %     9.2 %                     9.4 %
                                                 
 Normalized Adjusted EBITDAR margin
    17.4 %     6.8 %     10.1 %                     13.3 %
                                                 
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Income to Adjusted EBITDA and
 
     Adjusted EBITDAR".
                                               
See normalizing adjustments in the table "Normalizing Adjustments - Quarter Comparison".
                 

 
13 of 16

 

Sun Healthcare Group, Inc. and Subsidiaries
 
Selected Operating Statistics
 
Continuing Operations
 
                                                 
   
For the
   
For the
 
   
Three Months Ended
   
Twelve Months Ended
 
   
December 31,
   
December 31,
 
   
2010
   
2009
   
2010
   
2009
 
Consolidated Company
                                               
                                                 
Revenues - Non-affiliated (in thousands)
                                           
Skilled Nursing and similar facilities
  $ 418,993           $ 411,019             1,649,677             1,641,571        
Hospice
    11,901             11,654             45,533             30,903        
Other - Inpatient Services
    570             555             2,234             2,278        
Inpatient Services
    431,464             423,228             1,697,444             1,674,752        
                                                         
Rehabilitation Therapy Services
    29,889             27,303             119,612             105,366        
Medical Staffing Services
    22,053             23,289             89,765             100,624        
Other - non-core businesses
    12             7             40             34        
Total
  $ 483,418           $ 473,827           $ 1,906,861           $ 1,880,776        
                                                         
                                                         
Revenue Mix - Non-affiliated (in thousands)
                                                 
Medicare
  $ 145,477       30 %   $ 137,511       29 %     566,874       30 %     554,570       29 %
Medicaid
    196,272       41 %     194,035       41 %     771,128       40 %     753,393       40 %
Private and Other
    112,815       23 %     112,702       24 %     452,309       24 %     454,126       25 %
Managed Care / Insurance
    23,518       5 %     25,004       5 %     96,153       5 %     101,595       5 %
Veterans
    5,336       1 %     4,575       1 %     20,397       1 %     17,092       1 %
Total
  $ 483,418       100 %   $ 473,827       100 %   $ 1,906,861       100 %   $ 1,880,776       100 %
                                                                 
     
                                                                 
Inpatient Services Stats
   
                                                                 
Number of centers:
    200               200               200               200          
Number of available beds:
    22,243               22,166               22,243               22,166          
Occupancy %:
    86.6 %             88.1 %             87.0 %             88.5 %        
                                                                 
                                                                 
Payor Mix % based on patient days:
                                                           
Medicare - SNF Beds
    14.1 %             14.9 %             14.9 %             15.6 %        
Managed care / Ins. - SNF Beds
    3.7 %             4.1 %             3.9 %             4.1 %        
    Total SNF skilled mix
    17.8 %             19.0 %             18.8 %             19.7 %        
                                                                 
Medicare
    12.9 %             13.5 %             13.6 %             14.2 %        
Medicaid
    63.1 %             61.7 %             62.4 %             60.7 %        
Private and Other
    19.3 %             20.0 %             19.2 %             20.3 %        
Managed Care / Insurance
    3.4 %             3.7 %             3.6 %             3.8 %        
Veterans
    1.3 %             1.1 %             1.2 %             1.0 %        
                                                                 
Revenue Mix % of revenues:
                                                       
Medicare - SNF Beds
    32.3 %             31.1 %             32.0 %             32.4 %        
Managed care / Ins. - SNF Beds
    5.8 %             6.3 %             6.0 %             6.4 %        
    Total SNF skilled mix
    38.1 %             37.4 %             38.0 %             38.8 %        
                                                                 
Medicare
    32.6 %             31.5 %             32.3 %             32.1 %        
Medicaid
    45.5 %             45.8 %             45.4 %             45.0 %        
Private and Other
    15.3 %             15.7 %             15.5 %             15.9 %        
Managed Care / Insurance
    5.4 %             5.9 %             5.6 %             6.0 %        
Veterans
    1.2 %             1.1 %             1.2 %             1.0 %        
                                                                 
                                                                 
Revenues PPD:
                                                           
Medicare (Part A)
  $ 515.62             $ 457.79             $ 476.59             $ 455.02          
Medicare Blended Rate (Part A & B)
  $ 558.85             $ 494.01             $ 517.05             $ 492.44          
Medicaid
  $ 174.59             $ 173.57             $ 173.62             $ 171.55          
Private and Other
  $ 184.23             $ 178.17             $ 184.77             $ 176.40          
Managed Care / Insurance
  $ 390.15             $ 370.11             $ 374.02             $ 372.93          
Veterans
  $ 239.33             $ 235.19             $ 240.88             $ 231.33          
 
                                                                 
Rehab contracts
 
                                                                 
Affiliated
    162               127               162               127          
Non-affiliated
    346               337               346               337          
                                                                 
Average Qtrly Revenue per Contract
(in thousands)
  $ 104             $ 100             $ 101             $ 97          
     


 
14 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
                                           
NORMALIZING ADJUSTMENTS - QUARTER COMPARISON
 
(in thousands, except per share data)
 
                                           
                                           
   
AS REPORTED - 4th QUARTER 2010
 
   
Revenue
   
Adjusted
EBITDAR
 
Adjusted
EBITDA
 
Pre-tax
   
Income from
Continuing
Operations
 
Disc Ops
   
Net Income
 
                                           
As Reported 4th QUARTER 2010
  $ 483,418     $ 28,114     $ 86     $ (48,956 )   $ (31,930 )   $ (446 )   $ (32,376 )
Percent of Revenue
            5.8 %     0.0 %     -10.1 %     -6.6 %     -0.1 %     -6.7 %
                                                         
Normalizing Adjustments:
                                                       
                                                         
Loss on sale of property
    -       -       -       847       500       -       500  
Loss on extinguishment of debt
    -       -       -       29,221       17,240       -       17,240  
Transaction costs related to acquisition
    -       446       446       446       263       -       263  
Prior periods' self-insurance costs and other
       general liability matters
    -       15,300       15,300       15,300       9,027       -       9,027  
REIT separation transaction costs
    -       22,117       22,117       22,117       16,096       -       16,096  
                                                         
Normalized As Reported-4th QUARTER 2010
  $ 483,418     $ 65,977     $ 37,949     $ 18,975     $ 11,196     $ (446 )   $ 10,750  
Percent of Revenue
            13.6 %     7.9 %     3.9 %     2.3 %     -0.1 %     2.2 %
                                                         
 As Reported
                                  $ (1.24 )   $ (0.02 )   $ (1.26 )
Diluted EPS:       As Normalized
                                  $ 0.43     $ (0.01 )   $ 0.42  
                                                         
                                                         
                                                         
                                                         
                                                         
   
AS REPORTED - 4th QUARTER 2009
   
   
Revenue
   
Adjusted
EBITDAR
 
Adjusted
EBITDA
 
Pre-tax
   
Income from
Continuing
Operations
 
Disc Ops
   
Net Income
 
                                                         
As Reported-4th QUARTER 2009
  $ 473,827     $ 59,465     $ 41,093     $ 16,631     $ 9,810     $ (1,135 )   $ 8,675  
Percent of Revenue
            12.5 %     8.7 %     3.5 %     2.1 %     -0.2 %     1.8 %
                                                         
Normalizing Adjustments:
                                                       
                                                         
Restructuring costs
    -       -       -       432       255       -       255  
Transaction costs related to acquisition
    -       485       485       485       286       -       286  
Prior periods' self-insurance costs
    -       3,920       3,920       3,920       2,313       313       2,626  
                                                         
Normalized As Reported-4th QUARTER 2009
  $ 473,827     $ 63,870     $ 45,498     $ 21,468     $ 12,664     $ (822 )   $ 11,842  
Percent of Revenue
            13.5 %     9.6 %     4.5 %     2.7 %     -0.2 %     2.5 %
                                                         
 As Reported
                                  $ 0.67     $ (0.08 )   $ 0.59  
 Diluted EPS:       As Normalized
                                  $ 0.86     $ (0.06 )   $ 0.80  
                                                         
                                                         
                                                         
                                                         
                                                         
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDAR".
 
                                                         
Normalizing adjustments are transactions or adjustments not related to ongoing operations and consist of: loss on sale of property, loss on extinguishment of debt, transaction costs related to acquisition, prior periods' self-insurance costs and other general liability matters, REIT separation transaction costs and restructuring costs.
 
   
Since normalizing adjustments are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations and interpretations, the information presented herein may not be comparable to other similarly described information of other companies.
 
                                                         
                                                         

 
15 of 16

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
                                           
NORMALIZING ADJUSTMENTS - YEAR TO DATE COMPARISON
 
(in thousands, except per share data)
 
                                           
                                           
   
AS REPORTED -TWELVE MONTHS 2010
     
   
Revenue
   
Adjusted
EBITDAR
 
Adjusted
EBITDA
 
Pre-tax
   
Income from
Continuing
Operations
 
Disc Ops
 
Net Income
 
                                           
As Reported-Twelve Months 2010
  $ 1,906,861     $ 205,722     $ 121,388     $ 248     $ (2,716 )   $ (1,934 )   $ (4,650 )
Percent of Revenue
            10.8 %     6.4 %     0.0 %     -0.1 %     -0.1 %     -0.2 %
                                                         
Normalizing Adjustments:
                                                       
                                                         
Loss on sale of property
    -       -       -       847       500       -       500  
Loss on extinguishment of debt
    -       -       -       29,221       17,240       -       17,240  
Transaction costs related to acquisition
    -       446       446       446       263       -       263  
Prior periods' self-insurance costs and other
       general liability matters
    -       15,300       15,300       15,300       9,027       -       9,027  
REIT separation transaction costs
    -       29,113       29,113       29,113       20,224       -       20,224  
                                                         
Normalized As Reported-Twelve Months 2010
  $ 1,906,861     $ 250,581     $ 166,247     $ 75,175     $ 44,538     $ (1,934 )   $ 42,604  
Percent of Revenue
            13.1 %     8.7 %     3.9 %     2.3 %     -0.1 %     2.2 %
                                                         
 As Reported
                                  $ (0.14 )   $ (0.10 )   $ (0.24 )
Diluted EPS:        As Normalized
                                  $ 2.31     $ (0.10 )   $ 2.21  
                                                         
                                                         
                                                         
                                                         
                                                         
   
AS REPORTED - TWELVE MONTHS 2009
 
   
Revenue
   
Adjusted
EBITDAR
 
Adjusted
EBITDA
 
Pre-tax
   
Income from
Continuing
Operations
 
Disc Ops
 
Net Income
 
                                                         
As Reported-Twelve Months 2009
  $ 1,880,776     $ 241,950     $ 168,822     $ 72,696     $ 43,080     $ (4,409 )   $ 38,671  
Percent of Revenue
            12.9 %     9.0 %     3.9 %     2.3 %     -0.2 %     2.1 %
                                                         
Normalizing Adjustments:
                                                       
                                                         
Restructuring costs
    -       -       -       1,304       769       -       769  
Transaction costs related to acquisition
    -       485       485       485       286       -       286  
Prior periods' self-insurance costs
    -       8,220       8,220       8,220       4,850       661       5,511  
                                                         
Normalized As Reported-Twelve Months 2009
  $ 1,880,776     $ 250,655     $ 177,527     $ 82,705     $ 48,985     $ (3,748 )   $ 45,237  
Percent of Revenue
            13.3 %     9.4 %     4.4 %     2.6 %     -0.2 %     2.4 %
                                                         
                                                         
 As Reported
                                  $ 2.93     $ (0.30 )   $ 2.63  
 Diluted EPS:       As Normalized
                                  $ 3.33     $ (0.26 )   $ 3.07  
                                                         
                                                         
                                                         
See definitions of Adjusted EBITDA and Adjusted EBITDAR in the table "Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDAR".
 
                                                         
Normalizing adjustments are transactions or adjustments not related to ongoing operations and consist of: loss on sale of property, loss on extinguishment of debt, transaction costs related to acquisition, prior periods' self-insurance costs and other general liability matters, REIT separation transaction costs and restructuring costs.
 
 
Normalizing adjustments do not include any adjustment for the August 2010 equity offering or the use of proceeds to pay down debt, avoiding interest expense.
 
                                                         
Since normalizing adjustments are not measurements determined in accordance with U.S. generally accepted accounting principles and are thus susceptible to varying calculations and interpretations, the information presented herein may not be comparable to other similarly described information of other companies.
 

 
16 of 16